跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 80,282 条关于
“High-Risk Myelodysplastic Syndrome”
全部
80,282
临床试验
58,366
药物
607
机构
255
资讯
21,054
去年
Study Reveals Significant Treatment Disparities in High-Risk Myelodysplastic Syndrome Patients
去年
Faron Pharmaceuticals Reports 43% Complete Remission Rate in High-Risk Myelodysplastic Syndrome Trial
去年
AbbVie's VERONA Trial for High-Risk Myelodysplastic Syndrome Fails to Meet Primary Survival Endpoint
2年前
Advancements in Higher-Risk MDS Treatment Strategies Explored
9个月前
GT Biopharma Advances GTB-3650 to Higher Dose Level in Phase 1 Blood Cancer Trial
去年
Ivosidenib Plus CPX-351 Shows Promise in IDH1-Mutated AML and High-Risk MDS Trial
5年前
FDA Lifts Partial Clinical Hold on RVU120 Trial in AML and MDS
9个月前
Curis Reports 62.5% Undetectable MRD Rate in AML Triplet Therapy Study at ASH 2025
去年
Curis to Announce Third Quarter 2024 Financial Results and Provide Corporate Update
9个月前
VERONA Trial Shows Mixed Results for Venetoclax-Azacitidine Combination in High-Risk MDS
第 1 页，共 2106 页
上一页
下一页
